Vaccine hesitancy in cancer patients: A rapid review

[1]  M. Hsairi,et al.  COVID-19 vaccine hesitancy among Tunisian cancer patients in the Salah Azaeiz Institute of Cancer , 2021, The European Journal of Public Health.

[2]  A. Mita,et al.  SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment , 2021, Annals of Oncology.

[3]  O. A. Ogun,et al.  Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study , 2021, The Lancet.

[4]  M. Noula,et al.  Acceptance of coronavirus disease 2019 vaccination by cancer patients in Cyprus: A cross-sectional study , 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[5]  C. Villarreal-Garza,et al.  Letter to Editor, Re: The first report on Covid-19 vaccine refusal by cancer patients in Italy: Early data from a single-institute survey , 2021, European Journal of Cancer.

[6]  W. Mullally,et al.  1595P Acceptance of COVID-19 vaccination among cancer patients in an Irish cancer centre , 2021, Annals of Oncology.

[7]  Jae-Weon Kim,et al.  Cancer Patients’ Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in Korea , 2021, Cancers.

[8]  R. Ramlau,et al.  Attitudes towards COVID-19 vaccination among cancer and internal medicine patients in Poland. , 2021, Advances in Clinical and Experimental Medicine.

[9]  H. Boussen,et al.  Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients , 2021, Supportive Care in Cancer.

[10]  K. Lam,et al.  Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate , 2021, Vaccines.

[11]  J. Leask,et al.  Communicating with patients and the public about COVID‐19 vaccine safety: recommendations from the Collaboration on Social Science and Immunisation , 2021, The Medical journal of Australia.

[12]  C. Villarreal-Garza,et al.  Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer. , 2021, JAMA oncology.

[13]  F. Cognetti,et al.  The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey , 2021, European journal of cancer.

[14]  F. Cognetti,et al.  The first report on Covid-19 vaccine refusal by cancer patients in Italy: early data from a single-institute survey , 2021, European Journal of Cancer.

[15]  Austin Waters,et al.  COVID-19 Vaccine Hesitancy Among Adolescent and Young Adult Cancer Survivors , 2021, JNCI cancer spectrum.

[16]  D. Sigorski,et al.  Attitudes of Patients with Cancer towards Vaccinations—Results of Online Survey with Special Focus on the Vaccination against COVID-19 , 2021, Vaccines.

[17]  S. Goldberg,et al.  COVID-19 vaccine hesitancy among individuals with cancer, autoimmune diseases, and other serious comorbid conditions , 2021, medRxiv.

[18]  K. Prabhash,et al.  COVID-19 vaccine uptake and vaccine hesitancy in Indian patients with cancer: A questionnaire-based survey , 2021 .

[19]  C. Cogle,et al.  Vaccine Enthusiasm and Hesitancy in Cancer Patients and the Impact of a Webinar , 2021, Healthcare.

[20]  E. Chamorey,et al.  Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey , 2021, Annals of Oncology.

[21]  K. Bhaskaran,et al.  Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data , 2020, EClinicalMedicine.

[22]  C. Garritty,et al.  Defining Rapid Reviews: a systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews. , 2020, Journal of clinical epidemiology.

[23]  D. Kerr,et al.  COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study , 2020, The Lancet Oncology.

[24]  Alokkumar Jha,et al.  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study , 2020, The Lancet.

[25]  M. Santillana,et al.  Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak , 2020, Cancer discovery.

[26]  V. Welch,et al.  Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline , 2020, BMJ.

[27]  Pierre Pluye,et al.  The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers , 2018, Educ. Inf..

[28]  N. Meader,et al.  Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. , 2011, The Lancet. Oncology.